311
Views
16
CrossRef citations to date
0
Altmetric
Non-themed Articles

Application of NIR chemometric methods for quantification of the crystalline fraction of warfarin sodium in drug product

, , , &
Pages 584-594 | Received 05 Mar 2015, Accepted 29 May 2015, Published online: 10 Jul 2015

References

  • Link KP. The discovery of dicumarol and its sequels. Circulation 1959;19:97–107
  • Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy. Circulation 2003;107:1692–711
  • Johnson JA. Warfarin pharmacogenetics: a rising tide for its clinical value. Circulation 2012;125:1964–6
  • Lip GY, Laroche C, Dan GA, et al. “Real-world” antithrombotic treatment in atrial fibrillation: the EORP-AF pilot survey. Am J Med 2014;127:519–29
  • United States Pharmacopeial Convention. United States Pharmacopeia. National Formulary. 29th ed. Baltimore (MD): United States Pharmacopeia; 2014:5171
  • Hiskey CF, Melnitchenko V. Clathrates of sodium warfarin. J Pharm Sci 1965;54:1298–302
  • Gao D, Maurin M. Physical chemical stability of warfarin sodium. AAPS PharmSci 2001;3:18–25
  • Brittain HG. Polymorphism in pharmaceutical solids. 192 ed. London: Informa Healthcare; 2009
  • Leading Drug Safety Issues of 2012. Institiute for Safe Medication Practices; 2013
  • Bugay DE. Characterization of the solid-state: spectroscopic techniques. Adv Drug Deliv Rev 2001;48:43–65
  • Dal Curtivo CP, Funghi NB, Tavares GD, et al. The critical role of NIR spectroscopy and statistical process control (SPC) strategy towards captopril tablets (25 mg) manufacturing process understanding: a case study. Pharm Dev Technol 2013;20:345–51
  • Fonteyne M, Vercruysse J, Diaz DC, et al. Real-time assessment of critical quality attributes of a continuous granulation process. Pharm Dev Technol 2011;18:85–97
  • Yang H, Liao X, Peng F, et al. Monitoring of the manufacturing process for ambroxol hydrochloride tablet using NIR-chemometric methods: compression effect on content uniformity model and relevant process parameters testing. Drug Dev Ind Pharm 2015. [Epub ahead of print]. doi: 10.3109/03639045.2015.1019354
  • Otsuka K, Uchino T, Otsuka M. Non-destructive prediction of the drug content of an acetaminophen suppository by near-infrared spectroscopy and X-ray computed tomography. Drug Dev Ind Pharm 2015;41:15–21
  • Boersen N, Carvajal MT, Morris KR, et al. The influence of API concentration on the roller compaction process: modeling and prediction of the post compacted ribbon, granule and tablet properties using multivariate data analysis. Drug Dev Ind Pharm 2014. [Epub ahead of print]. doi: 10.3109/03639045.2014.958754
  • Howland H, Fahmy R, Hoag SW. Analysis of curing of a sustained release coating formulation by application of NIR spectroscopy to monitor changes associated with glyceryl monostearate. Drug Dev Ind Pharm 2014;20:1–11
  • Blanco M, Villar A. Polymorphic analysis of a pharmaceutical preparation by NIR spectroscopy. Analyst 2000;125:2311–14
  • Rahman Z, Siddiqui A, Bykadi S, Khan MA. Near-infrared and fourier transform infrared chemometric methods for the quantification of crystalline tacrolimus from sustained-release amorphous solid dispersion. J Pharm Sci 2014;103:2376–85
  • Siddiqui A, Rahman Z, Sayeed VA, Khan MA. Chemometric evaluation of near infrared, Fourier transform infrared, and Raman spectroscopic models for the prediction of nimodipine polymorphs. J Pharm Sci 2013;102:4024–35
  • Rahman Z, Zidan AS, Khan MA. Non-destructive methods of characterization of risperidone solid lipid nanoparticles. Eur J Pharm Biopharm 2010;76:127–37
  • Fukui Y, Otsuka M. Determination of the crystallinity of cephalexin in pharmaceutical formulations by chemometrical near-infrared spectroscopy. Drug Dev Ind Pharm 2010;36:72–80
  • Otsuka M, Fukui Y. Determination of carbamazepine polymorphic contents in double-layered tablets using transmittance- and reflectance-near-infrared spectroscopy involving chemometrics. Drug Dev Ind Pharm 2010;36:1404–12
  • Lee KR, Zuber G, Katrincic L. Chemometrics approach to the determination of polymorphism of a drug compound by infrared spectroscopy. Drug Dev Ind Pharm 2000;26:135–47
  • Arruabarrena J, Coello J, Maspoch S. NIR reflectance determination of warfarin in a solid preparation commercialized at different API mass proportions. Anal Methods 2013;5:3858–63
  • Westenberger BJ, Ellison CD, Fussner AS, et al. Quality assessment of internet pharmaceutical products using traditional and non-traditional analytical techniques. Int J Pharm 2005;306:56–70
  • Siesler HW, Ozaki Y, Kawata S, Heise HM. Near-infrared spectroscopy: principles, instruments, applications. Hoboken (NJ): John Wiley & Sons; 2008
  • Gendrin C, Roggo Y, Collet C. Pharmaceutical applications of vibrational chemical imaging and chemometrics: a review. J Pharm Biomed Anal 2008;48:533–53
  • Rinnan A, Berg Fd, Engelsen SB. Review of the most common pre-processing techniques for near-infrared spectra. Trends Anal Chem 2009;28:1201–22
  • Geladi P, MacDougall D, Martens H. Linearization and scatter-correction for near-infrared reflectance spectra of meat. Appl Spectrosc 1985;39:491–500
  • Martens H, Nielsen JP, Engelsen SB. Light scattering and light absorbance separated by extended multiplicative signal correction. Application to near-infrared transmission analysis of powder mixtures. Anal Chem 2003;75:394–404
  • Ferreira AP, Tobyn M. Multivariate analysis in the pharmaceutical industry: enabling process understanding and improvement in the PAT and QbD era. Pharm Dev Technol 2014. [Epub ahead of print]. doi: 10.3109/10837450.2014.898656
  • Tobias RD. Chemometrics: a practical guide. Technometrics 1999;41:375–6
  • Sun J. A correlation principal component regression analysis of NIR data. J Chemometr 1995;9:21–9
  • Naes T, Martens H. Principal component regression in NIR analysis: viewpoints, background details and selection of components. J Chemometr 1988;2:155–67
  • Reich G. Near-infrared spectroscopy and imaging: basic principles and pharmaceutical applications. Adv Drug Deliv Rev 2005;57:1109–43

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.